Injectable GLP-1 · Brand name
Zepbound
Prescription only. Prescribed only if a licensed provider determines it is appropriate for you.
$1,099/mo
Includes your provider consult and the medication, shipped to you.
Provider-reviewed · Cancel anytime
Safety, risks & side effects
Review these risks with a licensed provider and read the full prescribing information before starting.
Boxed warning: In rodent studies, tirzepatide caused thyroid C-cell tumors. It is not known whether Zepbound causes these tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use if you or a family member has had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects
- Nausea
- Diarrhea or constipation
- Vomiting
- Abdominal pain
- Decreased appetite
Serious risks
- Pancreatitis (inflammation of the pancreas)
- Gallbladder problems
- Low blood sugar, especially with other diabetes medicines
- Kidney problems related to dehydration
- Serious allergic reactions
Do not use if you have
- Personal or family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Known serious allergy to tirzepatide
- Pregnancy or breastfeeding
Zepbound is a registered trademark of Eli Lilly and Company. Josie is not affiliated with, endorsed by, or sponsored by Eli Lilly.
Medications are only issued when clinically appropriate after a provider evaluation. Prescription medications carry risks; read the full prescribing information before use.